Dexamethasone improves thymoma-associated myasthenia gravis via the AKT-mTOR pathway
Dexamethasone improves thymoma-associated myasthenia gravis via the AKT-mTOR pathway
About this item
Full title
Author / Creator
Liu, Yuxin , Chen, Si , Wang, Yan , Zhang, Zeyang , Zhang, Hui , Wang, Ziyi , Tao, Ziyou , Wang, Jianyao and Zhang, Peng
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Clinically, thymoma patients are often complicated with myasthenia gravis (MG). Dexamethasone, a glucocorticoid with anti-inflammatory effects, could be used as an immunosuppressant for thymoma-associated MG, but the mechanism of action remains to be explored. In this study, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) anal...
Alternative Titles
Full title
Dexamethasone improves thymoma-associated myasthenia gravis via the AKT-mTOR pathway
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10791733
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10791733
Other Identifiers
ISSN
0028-1298
E-ISSN
1432-1912
DOI
10.1007/s00210-023-02641-z
